NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $42,576,000 | -3.7% | 1,190,263 | -30.0% | 2.50% | -24.3% |
| Q3 2014 | $44,189,000 | +119.4% | 1,699,562 | +178.9% | 3.30% | +120.1% |
| Q2 2014 | $20,137,000 | -22.7% | 609,300 | -30.0% | 1.50% | +39.3% |
| Q1 2014 | $26,052,000 | +95.4% | 870,400 | +98.2% | 1.08% | -13.4% |
| Q4 2013 | $13,331,000 | – | 439,100 | – | 1.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVEY CAPITAL MANAGEMENT INC | 424,175 | $12,695,000 | 5.06% |
| Opaleye Management Inc. | 150,000 | $4,490,000 | 3.32% |
| OAK RIDGE INVESTMENTS LLC | 2,795,331 | $83,664,000 | 2.10% |
| SCHOLTZ & COMPANY, LLC | 60,350 | $1,806,000 | 1.94% |
| SECTORAL ASSET MANAGEMENT INC | 1,408,729 | $42,163,000 | 1.73% |
| First Light Asset Management, LLC | 79,099 | $2,367,000 | 1.68% |
| FCG ADVISORS, LLC | 71,146 | $2,129,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 166,970 | $4,997,000 | 1.50% |
| BENDER ROBERT & ASSOCIATES | 73,611 | $2,203,000 | 1.48% |
| Eventide Asset Management | 283,900 | $8,497,000 | 1.32% |